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Early Biometric Lag in the Prediction of Small for Gestational Age Neonates and
Preeclampsia
Abstract
OBJECTIVE: An early fetal growth lag may be a marker of future complications. We sought to determine
the utility of early biometric variables in predicting adverse pregnancy outcomes.
METHODS: In this retrospective cohort study, the crown-rump length at 11 to 14 weeks and the head
circumference, biparietal diameter, abdominal circumference, femur length, humerus length, transverse
cerebellar diameter, and estimated fetal weight at 18 to 24 weeks were converted to an estimated
gestational age using published regression formulas. Sonographic fetal growth (difference between each
biometric gestational age and the crown-rump length gestational age) minus expected fetal growth
(number of days elapsed between the two scans) yielded the biometric growth lag. These lags were
tested as predictors of small for gestational age (SGA) neonates (≤10th percentile) and preeclampsia.
RESULTS: A total of 245 patients were included. Thirty-two (13.1%) delivered an SGA neonate, and 43
(17.6%) had the composite outcome. The head circumference, biparietal diameter, abdominal
circumference, and estimated fetal weight lags were identified as significant predictors of SGA neonates
after adjusted analyses (P < .05). The addition of either the estimated fetal weight or abdominal
circumference lag to maternal characteristics alone significantly improved the performance of the
predictive model, achieving areas under the curve of 0.72 and 0.74, respectively. No significant
association was found between the biometric lag variables and the development of preeclampsia.
CONCLUSIONS: Routinely available biometric data can be used to improve the prediction of adverse
outcomes such as SGA. These biometric lags should be considered in efforts to develop screening
algorithms for adverse outcomes.
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Objectives—An early fetal growth lag may be a marker of future complications.
We sought to determine the utility of early biometric variables in predicting adverse
pregnancy outcomes.
Methods—In this retrospective cohort study, the crown-rump length at 11 to 14 weeks
and the head circumference, biparietal diameter, abdominal circumference, femur
length, humerus length, transverse cerebellar diameter, and estimated fetal weight at 18
to 24 weeks were converted to an estimated gestational age using published regression
formulas. Sonographic fetal growth (difference between each biometric gestational age
and the crown-rump length gestational age) minus expected fetal growth (number of
days elapsed between the two scans) yielded the biometric growth lag. These lags were
tested as predictors of small for gestational age (SGA) neonates (≤10th percentile) and
preeclampsia.
Results—A total of 245 patients were included. Thirty-two (13.1%) delivered an SGA
neonate, and 43 (17.6%) had the composite outcome. The head circumference,
biparietal diameter, abdominal circumference, and estimated fetal weight lags were identified as significant predictors of SGA neonates after adjusted analyses (P < .05). The addition of either the estimated fetal weight or abdominal circumference lag to maternal
characteristics alone significantly improved the performance of the predictive model,
achieving areas under the curve of 0.72 and 0.74, respectively. No significant association
was found between the biometric lag variables and the development of preeclampsia.
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Conclusions—Routinely available biometric data can be used to improve the prediction of adverse outcomes such as SGA. These biometric lags should be considered in
efforts to develop screening algorithms for adverse outcomes.
Key Words—biometry; fetal growth restriction; intrauterine growth restriction;
preeclampsia; sonography

E

arly reliable predictors of placental dysfunction remain lacking in obstetric care. In reality, it is likely that no single test
will achieve sufficient accuracy to be used in clinical practice
as a stand-alone test in the prediction of pregnancy complications.
Early identification of a pregnancy at risk of impaired fetal growth
and an adverse outcome may allow for increased fetal surveillance
to be implemented with the goal of preventing an adverse outcome.
In addition, future medical advances may yield effective therapeutic options that, if used early in appropriately identified high-risk
pregnancies, may decrease the incidence of adverse outcome.
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Although there is an abundance of evidence linking
various maternal serum analytes and uterine artery
Doppler measurements with adverse pregnancy outcomes,1–3 no single test has proved effective as a screening
tool. Rather, recent evidence has shown that maternal risk
factors, serum markers, and uterine artery Doppler studies can be combined in various ways to improve the overall prediction of adverse obstetric outcomes, such as fetal
growth restriction and preeclampsia.4–6 Thus, the identification of additional early predictors of adverse outcomes
may prove instrumental in the development of effective
screening strategies.
It is biologically plausible that early lags in fetal biometry are a result of early placental dysfunction, leading to
slowed fetal growth. It may be that in some cases, the
growth lag persists and results in clinical growth restriction. In other cases, the growth lag may remain subclinical as continued placental growth and villous arborization
are sufficient to support adequate fetal growth. However,
the impact of impaired early placental development may
still manifest as other obstetric complications such as
preeclampsia. In fact, several studies have shown that a lag
in biparietal diameter growth between the first and second
trimesters is associated with adverse pregnancy outcomes,
including small-for-gestational-age (SGA) neonates, low
birth weight, preterm birth, and fetal death.7–9 Similarly,
Fox et al10 retrospectively examined a composite estimated
fetal weight and found that pregnancies with an estimated
fetal weight below the 25th percentile for gestational age at
16 to 24 weeks were associated with increased rates of SGA
neonates, low birth weight, indicated preterm birth,
preeclampsia, and perinatal death. Thus, early biometric
variables have the potential to serve as readily available predictors of adverse pregnancy outcomes.
We sought to expand on the existing evidence related
to early biometry as a predictor of adverse outcomes by investigating whether other biometric parameters commonly
recorded during the anatomic survey can be used to help
identify pregnancies at risk for adverse outcomes.

Materials and Methods
The study population consisted of women who were enrolled in a prospective study investigating 3-dimensional
placental sonography in early pregnancy. These women
presented for nuchal translucency screening at 11 to 14
weeks and provided written informed consent. This protocol was approved by the Institutional Review Board. For
this study, we identified women who underwent sonographic biometric assessment in our unit at both 11 to 14
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and 18 to 24 weeks and for whom delivery outcome data
were available.
This was the starting reference point for use in our calculation of interval fetal growth. The crown-rump length
was collected from the first-trimester sonographic examination, and the biparietal diameter, head circumference,
abdominal circumference, femur length, humerus length,
and transverse cerebellar diameter were collected from the
second-trimester anatomic survey. Each biometric variable
was converted to an estimated gestational age by commonly used published regression formulas.11–15 For the
purposes of our study, the gestational age based on the estimated fetal weight was calculated using the regression
equation that includes the head circumference, biparietal
diameter, abdominal circumference, and femur length because the combination of these 4 biometric parameters is
commonly used to estimate the fetal weight on sonography (Table 1).
Interval fetal growth was calculated as the difference in
the estimated gestational age (in days) between the two
scans. We then calculated the biometric growth lag for each
variable as the difference between the observed interval
growth and the expected interval growth (ie, the number of
calendar days elapsed between the first and second sonographic examinations). For example, if 8 weeks elapsed between the first-trimester scan and the second-trimester
anatomic survey, then the expected growth would be 56
days. If the crown-rump length measurement estimated
the gestational age to be 12 weeks and the biparietal diameter at the anatomic survey estimated the gestational age to
be 19 weeks 2 days, then the observed biparietal diameter
growth would be 7 weeks 2 days or 51 days. A biparietal
diameter lag of –5 days (51–56) is the difference between
Table 1. Biometry Regression Formulas
Biometric
Variable

CRL11

HC12
BPD13
AC13
FL13
EFW13
HL14
TCD15

Regression
Formula

Ln(GA) = 1.684969 + (0.315646 * CRL) –
(0.049306 * CRL2) + (0.004057 * CRL3) –
(0.000120456 * CRL4)
GA = 8.8 + 0.55 * HC + 0.0003 * HC3
GA = 9.54 + 1.482 * BPD + 0.1676 * BPD2
GA = 8.14 + 0.753 * AC + 0.0036 * AC2
GA = 10.35 + 2.46 * FL + 0.17 * FL2
GA = 10.85 + 0.06 * HC * FL + 0.67 * BPD + 0.168 * AC
GA = 9.6519438 + 0.26200391 * HL + 0.0026105367 * HL2
GA = 8.119 + 4.244 * TCD + 1.1130 * TCD2 - 0.169 * TCD3

AC indicates abdominal circumference; BPD, biparietal diameter;
CRL, crown-rump length; EFW, estimated fetal weight; FL, femur
length; GA, gestational age; HC, head circumference; HL, humerus
length; and TCD, transverse cerebellar diameter.
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the observed and expected growth. By defining an interval
growth between two sonographic measurements, we
avoided the potential variability and inaccuracy associated
with the last menstrual period.
Outcome data were collected from the hospital medical record at time of delivery. Data collected included maternal age, parity, ethnicity, gestational age at delivery, birth
weight, and the presence or absence of preeclampsia. Gestational age was based on first-trimester sonographic dating if a definite last menstrual period was not available or if
there was a greater than 7-day discrepancy between menstrual dating and first-trimester sonographic biometric
measurements.
The primary outcomes of the study were delivery of
an SGA neonate and the development of preeclampsia.
Small for gestational age was defined as a birth weight at
or below the 10th percentile for gestational age using a national reference nomogram.16 A diagnosis of preeclampsia
required systolic blood pressure elevations of greater than
140 mm Hg or a diastolic blood pressure of greater than 90
mm Hg and documentation of at least 1+ protein on a
urine dipstick test or a 24-hour urine collection with greater
than 300 mg of protein.
Univariate analyses were first performed to identify
potential associations between predictor variables and
outcome variables. The Student t test was used for continuous variables because the data were not particularly
skewed. χ2 and Fisher exact tests were used for categorical
variables. Parity was analyzed as a dichotomous variable
(nulliparous or parous). Logistic regression was used to
predict adverse outcomes, and receiver operator characteristic (ROC) curves were constructed for the biometric variables found to have significant associations with
outcomes. Test performance characteristics were calculated for candidate cut points for each significant biometric variable. Finally, background variables were added
to the logistic regression to adjust for potential confounders. Adjusted ROC curves were constructed, and
the areas under the curve were recorded. These adjusted
curves were compared using tests of equality as described
by Cleves.17 Statistical analyses were performed using
StataIC version 10.1 software (StataCorp, College Station,
TX). P < .05 was considered statistically significant.

Results
We identified 245 patients who underwent first- and
second-trimester sonography in our unit and for whom
pregnancy outcome data were available. No major fetal
malformations or intrauterine deaths were encountered.

J Ultrasound Med 2011; 30:55–60

The mean (SD) gestational age at delivery in the cohort
was 39.1 (1.6) weeks, with 17 patients delivering before 37
weeks, for a preterm birth rate of 6.9%. The mean birth
weight in this cohort was 3287 (491) g, with 32 patients
(13.1%) delivering an SGA neonate and 12 (4.9%) delivering a neonate weighing less than 2500 g. Thirteen
women (5.3%) had a diagnosis of preeclampsia. Eighteen
neonates (7.3%) required admission to the neonatal intensive care unit.
Demographic data regarding maternal age, parity, and
ethnicity are shown in Table 2. No statistically significant
difference was observed for the mean maternal age or ethnicity between those women who delivered an SGA neonate
and those who delivered an appropriate-for-gestational-age
neonate. There was, however, a statistically significant increase in the representation of nulliparous women among
those who delivered an SGA neonate (P = .04).
Fetuses who were eventually delivered SGA had a statistically significantly greater estimated fetal weight lag
(P = .007), head circumference lag (P = .017), and abdominal circumference lag (P = .001) during their secondtrimester anatomic survey (Table 3). In addition, there was
a trend toward a greater biparietal diameter lag (P = .055).
Mean femur length, humerus length, and transverse cerebellar diameter lags were not significantly different between groups.
We then chose various lag cut points for each of the
promising biometric lag variables (Table 4). As expected,
there was a trade-off between the screen-positive rate, sensitivity, and specificity for each biometric variable. The use
of a smaller lag to define a positive test result led to improved sensitivity in detecting a future SGA neonate but
Table 2. Demographic Characteristics

Characteristic

Maternal age, y,
mean (SD)
Parity, n (%)
Nulliparous
Parity ≥1
Ethnicity, n (%)
White
Asian
Hispanic
Black
Other

All
(n = 245)

Appropriate for
Gestational
Age (n = 211)

Small for
Gestational
Age (n = 32)

34.0 (4.4)

34.1 (4.4)

33.6 (3.9)

142 (58.4)
101 (41.6)

118 (55.9)
93 (44.1)

24 (75)
8 (25)

143 (58.4)
56 (22.9)
30 (12.2)
15 (6.1)
1 (0.4)

128
48
24
12
1

15
8
6
3
0

P

.56a
.04b

.42c

aStudent t test.
bχ2 test.
cFisher exact test.
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Table 3. Relationship Between Biometric Lags and Small for Gestational Age
Sonographic
Variable

EFW lag
HC lag
BPD lag
AC lag
FL lag
HL lag (n = 243)
TCD lag (n = 175)

Appropriate for
Gestational Agea

Small for
Gestational Agea

Pb

aORc

Pc

–2.4 (–2.8 to –1.9)
–2.3 (–2.8 to –1.7)
–0.1 (–0.8 to 0.6)
0.9 (0.3 to 1.5)
–0.2 (–0.8 to 0.5)
2.0 (1.3 to 2.8)
–0.6 (–1.5 to 0.4)

–4.1 (–5.0 to –3.2)
–4.1 (–5.4 to –2.8)
–2.0 (–3.6 to –0.4)
–1.9 (–3.2 to –0.6)
–1.4 (–2.8 to 0.0)
2.3 (0.7 to 3.9)
–2.1 (–3.7 to –0.5)

.007
.017
.055
.001
.18
.8
.2

0.84 (0.75 to 0.95)
0.88 (0.80 to 0.97)
0.92 (0.86 to 0.995)
0.86 (0.78 to 0.95)

.005
.01
.037
.002

AC indicates abdominal circumference; aOR, adjusted odds ratio; BPD, biparietal diameter; EFW, estimated fetal weight; FL, femur length;
HC, head circumference; HL, humerus length; and TCD, transverse cerebellar diameter.
aMean biometric lag in days (95% confidence interval).
bStudent t test.
cAdjusted for maternal age, ethnicity, and parity.

at the expense of a higher screen-positive rate and lower
specificity. Thus, although the sensitivities ranged from
21% to 78%, the higher sensitivities seen with the estimated
fetal weight and head circumference lags were associated
with screen positive rates of greater than 40% and specificities of no more than 61%. It can be argued that the optimal trade-off from among these variables comes with the
use of an abdominal circumference lag of –3 days, which
detected almost 45% of SGA neonates with just more than
one-fourth of patients screening positive. However, even
with this definition, only 1 of 5 screen-positive women delivered an SGA neonate when the abdominal circumference lag was used as a stand-alone test.
In the multivariable models, the estimated fetal
weight, head circumference, biparietal diameter, and abdominal circumference lags remained significantly associated with SGA neonates even after adjusting for maternal
characteristics (age, ethnicity, and parity; Table 3).

In Figure 1, the ROC curve for maternal characteristics alone is plotted alongside the curves obtained when
each biometric lag variable was included in the adjusted
model. The addition of the estimated fetal weight lag (P =
.037) or abdominal circumference lag (P = .016) to maternal characteristics resulted in a statistically significant
improvement in the model’s performance. On the other
hand, the addition of the biparietal diameter lag (P = .13)
or head circumference lag (P = .12) to maternal characteristics did not result in a statistically significant improvement in testing performance compared with maternal
characteristics alone.
There were no significant differences in mean lags for
any of the biometric variables between pregnancies that
developed preeclampsia and those that did not (Table 5).

Table 4. Test Characteristics for Biometric Lags as Predictors of Small for Gestational Age
Sonographic
Variable

EFW lag

AC lag

HC lag

BPD lag

Cut
Point, d

Screen-Positive
Rate, %

Sensitivity, %
(95% CI)

Specificity, %
(95% CI)

Positive Predictive
Value, % (95% CI)

Negative Predictive
Value, % (95% CI)

–3
–4
–5
–3
–4
–5
–3
–4
–5
–3
–4
–5

52.2
42.4
29.8
27.8
20.0
14.3
49.4
41.6
33.5
35.1
28.6
20.8

78.1 (59.6 to 90.1)
65.6 (46.8 to 80.8)
37.5 (21.7 to 56.3)
43.8 (26.8 to 62.1)
28.1 (14.4 to 47.0)
21.9 (9.9 to 40.4)
68.8 (49.9 to 83.3)
59.4 (40.8 to 75.8)
46.9 (29.5 to 65)
53.1 (35.0 to 70.5)
40.6 (24.2 to 59.2)
25.0 (12.1 to 43.8)

51.6 (44.7 to 58.5)
61.0 (54.1 to 67.6)
71.4 (64.7 to 77.2)
74.6 (68.2 to 80.2)
81.2 (75.2 to 86.1)
86.9 (81.4 to 90.9)
53.5 (46.6 to 60.3)
61.0 (54.1 to 67.6)
68.5 (61.8 to 74.6)
67.6 (60.8 to 73.7)
73.2 (66.7 to 78.9)
79.8 (73.7 to 84.9)

19.5 (13.3 to 27.7)
20.2 (13.2 to 29.4)
16.4 (9.1 to 27.3)
20.6 (12.1 to 32.5)
18.4 (9.2 to 32.5)
20.0 (9.1 to 37.5)
18.2 (12 to 26.5)
18.6 (11.9 to 27.8)
18.3 (10.9 to 28.7)
19.8 (12.3 to 30.0)
18.6 (10.6 to 30.0)
15.7 (7.5 to 29.1)

94.0 (87.6 to 97.4)
92.2 (86.1 to 95.8)
88.4 (82.4 to 92.6)
89.8 (84.2 to 93.7)
88.3 (82.7 to 92.3)
80 (62.5 to 90.9)
91.9 (85.3 to 95.8)
90.9 (84.7 to 94.9)
89.6 (83.6 to 93.6)
90.6 (84.6 to 94.4)
89.1 (83.3 to 93.2)
87.6 (82 to 91.8)

AC indicates abdominal circumference; BPD, biparietal diameter; CI, confidence interval; EFW, estimated fetal weight; and HC, head circumference.
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Discussion
This study confirms the presence of early biometric lags in
fetuses destined to be delivered SGA. Although the test
characteristics of any single biometric lag variable are suboptimal for use as a stand-alone screening test, the addition of biometric lag variables to maternal characteristics
improves overall prediction. In fact, incorporating the estimated fetal weight or abdominal circumference lag in
the screening models for predicting SGA neonates led to
statistically significant improvements in the ROCs of the
model.
Many obstetric complications first become clinically
apparent in the later stages of pregnancy. However, it is generally believed that many placenta-related complications
such as fetal growth restriction and preeclampsia are related
to poor trophoblastic invasion and placental development
in early pregnancy. Therefore, it is biologically plausible that
subtle signs of early placental inefficiency or dysfunction
may serve as markers for future clinical disease.
Figure 1. Receiver operating characteristic curves using each of the significant biometric lag variables adjusted for maternal characteristics
(age, ethnicity, and parity) in the prediction of small for gestational age
neonates. The receiver operating characteristic curve using maternal
characteristics alone is also displayed. Area under the curve values are
shown, along with the P values for the comparison of each adjusted
biometric lag model with the model using only maternal characteristics.
The receiver operating characteristic curves for the estimated fetal
weight lag and abdominal circumference lags are significantly more predictive than the curve for maternal characteristics alone. AC indicates
abdominal circumference; BPD, biparietal diameter; EFW, estimated
fetal weight; and HC, head circumference.

Although fetal growth restriction has been associated
with both short- and long-term adverse outcomes,18,19
studies show that approximately one-third of growthrestricted fetuses remain undetected before delivery.20
Although the greater fetal growth velocity in the late second and early third trimesters may allow for the emergence
of clinically apparent growth restriction, smaller deviations
from optimal growth in the first half of pregnancy may
serve as early markers of future disease. Such early detection may lend itself to increased antenatal detection of fetal
growth restriction and may allow for increased fetal surveillance to decrease the incidence of adverse outcomes
such as fetal death. Furthermore, the identification of early
predictors of other adverse outcomes such as preeclampsia may also allow for a more targeted approach to the investigation of candidate interventions being studied as
potential therapies for these disease states.
Several studies have focused on biparietal diameter
growth as an early predictor of outcomes.7–9 In one large
retrospective cohort, Pedersen et al8 used the biparietal diameter growth rate from the first to second trimester as a
predictor of adverse outcomes. Although their results indicated that biparietal diameter growth rates below the
2.5th percentile were associated with an increased risk of
perinatal death and intrauterine growth restriction, they limited their analysis to the biparietal diameter and did not investigate other biometric parameters as potential predictors.
The lack of a convincing association between the biparietal
diameter lag and outcome in our study may have been due
to the small size of our cohort, which limited our ability to
detect a statistically significant difference. Nevertheless, the
significant associations between both estimated fetal weight
and abdominal circumference lags and SGA neonates in
our small cohort indicate that other biometric variables may
be even more predictive than the biparietal diameter lag.
Table 5. Relationship Between Biometric Lags and Preeclampsia
Sonographic
Variable

No Preeclampsiaa

Preeclampsiaa

EFW lag
–2.6 (–3.1 to –2.2) –2.3 (–4.2 to –4.6)
HC lag
–3.7 (–1.0 to 0.3)
0 (–3.6 to 3.6)
BPD lag
–2.5 (–3.0 to –2.0) –3.2 (–5.1 to –1.2)
AC lag
0.4 (–0.2 to 1.0)
2.4 (–0.6 to 5.4)
FL lag
–0.4 (–1.0 to 0.2)
–0.2 (–3.6 to 3.3)
HL lag (n = 243)
2.0 (+1.3 to 2.6)
3.7 (–1.4 to 8.9)
TCD lag (n = 175) –0.8 (–1.7 to 0.1)
–0.4 (–3.9 to 3.1)

Pb

.8
.8
.6
.1
.9
.2
.9

AC indicates abdominal circumference; BPD, biparietal diameter;
EFW, estimated fetal weight; FL, femur length; HC, head circumference; HL, humerus length; and TCD, transverse cerebellar diameter.
aMean biometric lag in days (95% confidence interval).
bStudent t test.
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In addition, because the abdominal circumference also
plays a significant role in the estimated fetal weight formula,
lags in abdominal circumference and estimated fetal weight
may be early manifestations of “brain sparing,” in which
preferential shunting of blood to the brain leads to slower
growth of the abdominal circumference.
The relatively small size of this study cohort limited
our ability to expand on the number of risk factors included
in our prediction models. For example, a larger cohort
would have allowed us to analyze additional variables such
as the body mass index, prior pregnancy history, and medical comorbidities to develop a clinically effective screening
tool. However, although such a research goal would certainly be an important one, it would require a very large cohort with an extensive database of historical and clinical
information to achieve. Thus, such extensive analyses were
outside the scope of our study. Rather, our results argue
that biometric lags have the potential to serve as biologically plausible and easily obtainable variables that have significant associations with SGA neonates. To this end, this
study supports this hypothesis by showing the significant
improvement in testing characteristics when adding biometric lags, such as the estimated fetal weight and abdominal circumference lags, to maternal age and ethnicity.
It remains to be seen whether these findings remain significant when more robust prediction models are used.
Our analyses did not reveal a significant association
between early biometric lags and preeclampsia. Although
this may also be due to the limited size of our cohort, these
results are in agreement with those of Pedersen et al,8 who
reported no association between early biparietal diameter
growth rates and preeclampsia.
Although many pregnancy complications are believed
to be manifestations of placental dysfunction, the exact
mechanisms leading to the various adverse outcomes are
poorly understood. To date, no single biomarker has been
identified as an accurate predictor of outcomes. However,
recent efforts have shown that readily available demographic and clinical variables can improve the performance
of novel predictors. Our results support the consideration
of early biometric lags in research efforts seeking to develop
a clinically reliable screening approach to predict adverse
pregnancy outcomes such as SGA.

2.

3.

4.

5.

6.

7.
8.

9.

10.
11.

12.
13.

14.
15.

16.
17.
18.

References
19.
1.

60

Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated
with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;
30:918–949.

20.

Tjoa ML, Oudejans CB, van Vugt JM, Blankenstein MA, van Wijk IJ. Markers
for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy2004; 23:171–189.
Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ2008;178:701–711.
Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–
13 weeks. Ultrasound Obstet Gynecol2010; 35:662–670.
Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in
pregnancy: combined screening by uterine artery Doppler, blood pressure and
serum PAPP-A at 11–13 weeks. Prenat Diagn2010; 30:216–223.
Pilalis A, Souka AP, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth
restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation.
Ultrasound Obstet Gynecol2007; 29:135–140.
Pedersen NG, Figueras F, Wojdemann KR, Tabor A, Gardosi J. Early fetal size and
growth as predictors of adverse outcome. Obstet Gynecol 2008; 112:765–771.
Pedersen NG, Wojdemann KR, Scheike T, Tabor A. Fetal growth between the
first and second trimesters and the risk of adverse pregnancy outcome. Ultrasound
Obstet Gynecol2008; 32:147–154.
Nakling J, Backe B. Adverse obstetric outcome in fetuses that are smaller than expected at second trimester routine ultrasound examination. Acta Obstet Gynecol
Scand2002; 81:846–851.
Fox NS, Huang M, Chasen ST. Second-trimester fetal growth and the risk of poor
obstetric and neonatal outcomes. Ultrasound Obstet Gynecol 2008; 32:61–65.
Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5–18 weeks) with high-resolution real-time
US. Radiology1992; 182:501–505.
Hadlock FP, Deter RL, Harrist RB, Park SK. Fetal head circumference: relation
to menstrual age. AJR Am J Roentgenol1982; 138:649–653.
Hadlock FP, Deter RL, Harrist RB, Park SK. Estimating fetal age: computerassisted analysis of multiple fetal growth parameters. Radiology1984; 152:497–
501.
Jeanty P, Rodesch F, Delbeke D, Dumont JE. Estimation of gestational age from
measurements of fetal long bones. J Ultrasound Med1984; 3:75–79.
Chavez MR, Ananth CV, Smulian JC, Yeo L, Oyelese Y, Vintzileos AM. Fetal
transcerebellar diameter measurement with particular emphasis in the third
trimester: a reliable predictor of gestational age. Am J Obstet Gynecol 2004;
191:979–984.
Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87:163–168.
Cleves M. From the help desk: comparing areas under receiver operating characteristic curves from two or more probit or logit models. Stata J 2002; 2:301–313.
van Wassenaer A. Neurodevelopmental consequences of being born SGA. Pediatr Endocrinol Rev2005; 2:372–377.
Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine
growth restriction. Clin Obstet Gynecol2006; 49:257–269.
American Congress of Obstetricians and Gynecologists. Practice bulletin
No. 12: intrauterine growth restriction. American Congress of Obstetricians
and Gynecologists website. http://www.acog.org/publications/educational_
bulletins/pb012.cfm. Accessed May 1, 2010.
J Ultrasound Med 2011; 30:55–60

